WO2003083088A3 - Stem cell therapy - Google Patents

Stem cell therapy Download PDF

Info

Publication number
WO2003083088A3
WO2003083088A3 PCT/GB2003/001325 GB0301325W WO03083088A3 WO 2003083088 A3 WO2003083088 A3 WO 2003083088A3 GB 0301325 W GB0301325 W GB 0301325W WO 03083088 A3 WO03083088 A3 WO 03083088A3
Authority
WO
WIPO (PCT)
Prior art keywords
cell
stem cell
cell therapy
ectoderm
endoderm
Prior art date
Application number
PCT/GB2003/001325
Other languages
French (fr)
Other versions
WO2003083088A2 (en
Inventor
Bitta Ruggero Della
Christopher Ralph Franks
Original Assignee
Bitta Ruggero Della
Christopher Ralph Franks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bitta Ruggero Della, Christopher Ralph Franks filed Critical Bitta Ruggero Della
Priority to AU2003217037A priority Critical patent/AU2003217037A1/en
Publication of WO2003083088A2 publication Critical patent/WO2003083088A2/en
Publication of WO2003083088A3 publication Critical patent/WO2003083088A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0611—Primordial germ cells, e.g. embryonic germ cells [EG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Abstract

A method of providing a primary germ layer cell for use in implant/transplant therapy, comprising providing a cell mass comprising an endoderm cell, an ectoderm cell and/or a mesoderm cell, and separating from the cell mass a primary germ layer cell selected from endoderm, ectoderm and mesoderm cells.
PCT/GB2003/001325 2002-03-28 2003-03-27 Stem cell therapy WO2003083088A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003217037A AU2003217037A1 (en) 2002-03-28 2003-03-27 Stem cell therapy

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0207299.9 2002-03-28
GBGB0207299.9A GB0207299D0 (en) 2002-03-28 2002-03-28 Stem cell therapy

Publications (2)

Publication Number Publication Date
WO2003083088A2 WO2003083088A2 (en) 2003-10-09
WO2003083088A3 true WO2003083088A3 (en) 2003-12-04

Family

ID=9933871

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2003/001325 WO2003083088A2 (en) 2002-03-28 2003-03-27 Stem cell therapy

Country Status (3)

Country Link
AU (1) AU2003217037A1 (en)
GB (1) GB0207299D0 (en)
WO (1) WO2003083088A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8815591B2 (en) 2005-06-24 2014-08-26 Icahn School Of Medicine At Mount Sinai Mesoderm and definitive endoderm cell populations

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003304106C1 (en) 2002-05-17 2010-10-28 Mount Sinai School Of Medicine Of New York University Mesoderm and definitive endoderm cell populations
US8874380B2 (en) 2010-12-09 2014-10-28 Rutgers, The State University Of New Jersey Method of overcoming therapeutic limitations of nonuniform distribution of radiopharmaceuticals and chemotherapy drugs
EP2731555B1 (en) 2011-07-13 2018-11-07 Vivex Biomedical, Inc. Spinal implants with stem cells

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007669A1 (en) * 1995-08-31 1997-03-06 Roslin Institute (Edinburgh) Quiescent cell populations for nuclear transfer
WO2000067568A1 (en) * 1999-05-06 2000-11-16 Stem Cell Sciences Pty Ltd A process of cell reprogramming through production of a heterokaryon
WO2002024873A1 (en) * 2000-09-20 2002-03-28 Christopher Ralph Franks Stem cell therapy

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007669A1 (en) * 1995-08-31 1997-03-06 Roslin Institute (Edinburgh) Quiescent cell populations for nuclear transfer
WO2000067568A1 (en) * 1999-05-06 2000-11-16 Stem Cell Sciences Pty Ltd A process of cell reprogramming through production of a heterokaryon
WO2002024873A1 (en) * 2000-09-20 2002-03-28 Christopher Ralph Franks Stem cell therapy

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ODORICO J S ET AL: "Multilineage differentiation from human embryonic stem cell lines.", STEM CELLS (DAYTON, OHIO) 2001, vol. 19, no. 3, 2001, pages 193 - 204, XP002256790, ISSN: 1066-5099 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8815591B2 (en) 2005-06-24 2014-08-26 Icahn School Of Medicine At Mount Sinai Mesoderm and definitive endoderm cell populations

Also Published As

Publication number Publication date
GB0207299D0 (en) 2002-05-08
AU2003217037A8 (en) 2003-10-13
WO2003083088A2 (en) 2003-10-09
AU2003217037A1 (en) 2003-10-13

Similar Documents

Publication Publication Date Title
IL188472A (en) Method for generating endoderm cells from human pluripotent stem cells
AU2002319054A1 (en) Multipotent stem cells from peripheral tissues and uses thereof
AU2002319780A1 (en) Alternative compositions and methods for the culture of stem cells
AU2003216058A8 (en) Mammalian neural stem cells, compositions and uses thereof
EP2266396A3 (en) Modulation of stem cells using zinc finger proteins
AU2003239159A8 (en) Placental derived stem cells and uses thereof
AU2003242976A1 (en) Methods of implanting mesenchymal stem cells for tissue repair and formation
GB0414558D0 (en) A method for the establishment of a pluripotent human blastocyst-derived stem cell line
EP1689854A4 (en) Placental stem cells and uses thereof
WO2003080801A3 (en) Adipose stromal stem cells for tissue and vascular modification
AU2001273041A1 (en) Methods for use of delivery composition for expanding, activating, committing ormobilizing one or more pluripotent, self-renewing and committed stem cells
WO2004000006A3 (en) Method of transforming soybean
AU2003241313A1 (en) Compositions and methods for stem cell delivery
EP1535994A4 (en) Human bone stem cells
AU2003210884A8 (en) Preparations of nucleus pulposus cells and methods for their generation, identification, and use
AU2001247638A1 (en) Flat, bonded-electrode rechargeable electrochemical cell and method of making same
WO2004015077A3 (en) Compositions and methods for neural differentiation of embryonic stem cells
WO2004031343A3 (en) Human foreskin cells suitable for culturing stem cells
EP1689377A4 (en) Stem cell culture medium and method of using said medium and the cells
AU2003280687A1 (en) Composition for culturing multipotent stem cells and utilization of the same
AU2003240628A1 (en) Method for establishing and expanding multipotent stem cells
AU2002348947A1 (en) Compositions and methods for amplification of human stem cells
AU2003209297A1 (en) Methods and compositions for preserving the viability of photoreceptor cells
AU2003287521A1 (en) Pluripotent cells from monocytes, and methods of making and using pluripotent cells
WO2003083088A3 (en) Stem cell therapy

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP